Life Science Company News

Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

West to Host Third-Quarter 2021 Conference Call

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

RadSite Announces First Wave of Cone Beam CT Imaging Accreditations

RadSite™, a leading accreditation organization promoting quality-based imaging practices, announced today that it has completed its first wave of accrediting Cone Beam CT imaging suppliers in the specialty areas of Dental, Maxillofacial, Orthopedics, and Podiatry. RadSite's Dental and Medical... Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Julia Jones Joins AMO Pharma As Chief Financial Officer And Board Member

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

IntoCell and Ab Studio to Start Research Collaboration

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies

- The Benevolent PlatformTM for AI-driven drug discovery identified and validated a novel biological target not previously linked to the disease;- BenevolentAI researchers nominated preclinical candidate within two years of novel target validation;- Ulcerative Colitis asset rapidly advancing to... Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc.

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

MindMaze and The Royal Buckinghamshire Hospital pioneer first U.K. location-based digital therapeutic solution for brain repair

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Clinical Trial Equipment & Ancillary Solutions Market Size Worth $4.4 Billion By 2028: Grand View Research, Inc.

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

FlowForma Selected To Deliver Workflow Software To NHS In London Procurement Partnership

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Global MEK Inhibitors Market Forecast 2026

Global MEK Inhibitors Market Offers Immense Potential Driven By New Product Launches And Increasing Clinical Pipeline Says Kuick Research Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Oblique Therapeutics is excited to present the recent progress on its anti-Thioredoxin mAb program at the annual meeting of Society for Immunotherapy of Cancer, Nov 10 - 14, Washington DC, USA

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Cantargia receives positive EMA opinion for orphan designation of nadunolimab for treatment of pancreatic cancer

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Micreos appoints Matt Regan as CEO of its Pharmaceutical business

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

UNION therapeutics announces enrollment of first patient in the OSIRIS Phase 2a study of oral orismilast for the treatment of mild to severe hidradenitis suppurativa

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Launch of New MolecuLightDX™ Device to Enable Point-of-Care Imaging of Wounds in New Expanding Market Segments

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Ketamine Wellness Centers Partners with Veterans Affairs (VA) Community Care Network to Provide Free Ketamine Treatments to Veterans

Read more ››
By: PR Newswire Association LLC. - 14 Oct 2021

Sarepta Therapeutics Announces Pricing of $500 Million Public Offering of Common Stock

Read more ››
By: GlobenewsWire - 14 Oct 2021

Roche’s Gazyvaro shorter 90-minute infusion time approved in Europe for people with previously treated or untreated follicular lymphoma

Read more ››
By: GlobenewsWire - 14 Oct 2021

New four-year data show Roche's ENSPRYNG significantly reduces debilitating relapses in people with neuromyelitis optica spectrum disorder

Read more ››
By: GlobenewsWire - 14 Oct 2021
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate